Comunicati.net - Comunicati pubblicati - Comuni Comunicati.net - Comunicati pubblicati - Comuni Wed, 20 Jan 2021 17:55:57 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://prwww.comunicati.net/comunicati/istituzioni/comuni/1 IL GRUPPO SAN DONATO DONA 3500 DOSI DI VACCINO ANTINFLUENZALE AD AVIS REGIONALE LOMBARDIA Tue, 19 Jan 2021 13:10:39 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/lombardia/684231.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/lombardia/684231.html RedazioneSB RedazioneSB  

Milano, 19 Gennaio 2021 – 3500 dosi di vaccino antinfluenzale sono state donate dal Gruppo San Donato ad Avis Regionale Lombardia, perché in questo scenario pandemico, non si può dimenticare il ruolo fondamentale dei donatori di sangue. 

 

La donazione che il Gruppo San Donato ha deciso di effettuare ad Avis ha come scopo quello di agevolare la protezione dei donatori e, contemporaneamente, consentire all’attività di donazione del sangue, servizio fondamentale per il sistema sanitario, di proseguire in totale sicurezza.

 

È fondamentale continuare a vaccinare contro il virus influenzale, quante più persone possibili, soprattutto i soggetti più fragili e a rischio, così da non sovraccaricare il lavoro dei medici di famiglia e degli ospedali. 

 

L’inizio della campagna vaccinale contro il Coronavirus è un importante traguardo raggiunto dalla scienza che permetterà di uscire dall’emergenza sanitaria. Tuttavia, ci vorranno mesi prima che tutti i cittadini riescano ad essere vaccinati. Per questo è fondamentale continuare parallelamente a contenere il virus influenzale, così da non acuire la situazione di stress a cui il sistema sanitario regionale è già sottoposto. 

 

“Il vaccino antinfluenzale rimane ad oggi l’unico mezzo disponibile ed efficace per contenere il virus influenzale e limitare di conseguenza l’accesso in ospedale soprattutto dei soggetti maggiormente a rischio”. Afferma Valerio Fabio Alberti, sovrintendente sanitario del Gruppo San Donato. “Abbiamo per questo deciso di donare ad Avis Regionale Lombardia 3500 vaccini per sostenere l’importante servizio dei donatori, aiutando a proteggere la loro salute”. 

 

Presenti alla consegna Gabriele Pagliarini, presidente di Avis Provinciale Brescia, Silvia Ghilardi, consigliere Avis Provinciale Bergamo e il presidente di Avis Regionale Lombardia Oscar Bianchi che dichiara: “A nome di tutti i donatori di Avis Regionale Lombardia, rivolgo il più sentito ringraziamento al Gruppo San Donato per la loro generosa donazione. Anche se in questi ultimi mesi la cronaca si è giustamente concentrata sulla lotta alla pandemia da Covid-19, non dobbiamo dimenticarci che il vaccino antinfluenzale resta un’arma fondamentale sia per i soggetti fragili sia per alleggerire la pressione negli ospedali. Il nostro intento è di raggiungere, con queste 3500 dosi, tutti i donatori delle Avis provinciali lombarde, affinché possano portare avanti la loro missione in completa salute e serenità”.

]]>
The Urinary Catheters Market To Surpass Covid-19 Cringe From 2021 Onwards Tue, 19 Jan 2021 10:19:33 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684190.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684190.html persistencemarketresearch persistencemarketresearch Global revenue of urinary catheters reached ~  1.5 billion  in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report,  the urinary catheters market  is estimated to grow  by ~ 4% YOY in 2019 , primarily attributed to ease of use, cost effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favored for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc.
  • Hollister Incorporate
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

According to the report, increasing focus on advanced urinary catheters coated with hydrogel, teflon, silicon, elastomer, etc., is rising owing to increasing concern of regulatory bodies across all regions to reduce the infection during catheterization process.

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity.

Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3268

The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery.

Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3268

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters.

In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market.

A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~ 4%. Accounting for ~ 23%  share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.

]]>
The Fall Detection System Market To Attain A Healthy Resolution Between 2019 to 2029 Tue, 19 Jan 2021 10:19:10 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684189.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684189.html persistencemarketresearch persistencemarketresearch The new research study by Persistence Market Research (PMR) unveils worldwide revenue of fall detection systems reached  US $ ~ 380 Mn , in 2018. According to the study, it is projected that the industry for  fall detection systems  is anticipated to expand by ~  4 %  YOY in 2019, mainly affected by the latest changes in the worldwide fall detection systems landscape such as technological advancements.

Growing focus on making highly sensitive and cost-effective fall detection systems contribute to the build-up of the industry for fall detection systems by the end of 2029, according to the study. Increasing number of falls in geriatric population combined with increasing prevalence of chronic diseases and endorsement of fall detection systems as supportive tool for independent living – all contribute to the upsurge in the sales of fall detection systems in 2019 and beyond.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/8878

Company Profile

  • Koninklijke Philips N.V.
  • Tunstall
  • ADT Inc.
  • Medical Guardian LLC.
  • BioTelemetry, Inc.
  • Bay Alarm Company
  • MobileHelp
  • MariCare Oy

Fall Injuries Increasing the Demand for Fall Detection Systems

Treatment of fall injuries imposes an enormous financial strain on the community, especially for seniors as the hospitalization time and cost of treatment increases with age. This is linked to rising ageing population coupled with increasing number of falls among the elderly group.

Fall detection systems deliver immediate access to elderly population and provides a potential solution for unreported falls among seniors, thus improving outcomes and reducing the overall healthcare cost. According to the Center for Diseases Control and Prevention, each year, 3 million seniors undergo treatment in emergency departments for fall injuries.

According to the PMR report, growing adoption in homecare settings accounted for relatively high sales in 2018, and this end-use sector will continue to harness the maximum share during the forecast period of 2019-2029. This is attributed to the growing desire for seniors to spent time at home and to live their life independently and at their convenience.

Demand for automatic fall detection systems is estimated to shoot up by the end of 2029, as end users seek user-friendly fall detection systems that have capability to alert senior care or healthcare facility automatically during emergency saving time for the patient to get proper therapy.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/8878

Based on sensing method, sales of wearable fall detection systems have been, and will continue to witness greater adoption among end users, reveals the PMR research study. Demand for wearable fall detection systems is primarily driven by their ease-of-use nature and mobility, as they come in the form of watches, necklaces, and clip-to-garments, thus enabling users to carry them wherever they wish to go.

Thus, the PMR study report estimates that wearable fall detection systems will hold ~ 70% of the total market share during the forecast period.

Asia Pacific Market Set to Grow 2X

According to the PMR study, growth opportunities for the fall detection systems market players are picking pace in the Asia Pacific region. After North America and Europe, Asia Pacific is expected to harness the maximum share in the market for fall detection systems, owing to subtle expansion of the regional healthcare industry and development of senior care facilities in this region.

High population factor and increasing investment in healthcare by the government, especially in Asian countries also create an opportunity for fall detection systems manufacturing companies to invest in these regions.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/8878

PMR's business analytics also shows breakthrough perspectives into the competitive landscape of the fall detection systems market along with highlights of manufacturers' key business policies and approaches.

Key market players in the fall detection systems will continue to draw upon the global drive by focusing their research and development resources on developing machine learning based fall detection systems and also companies will be expanding their business through partnerships with other technology giants.

For instance, MobileHelp®, an emerging company in the fall detection systems market, has taken a step further and created a new smart-watch based fall detection systems solution in collaboration with Samsung and Trelawear and announced the launch of new line of emergency response wearables to expand its product offerings of fall detection systems.

]]>
The Dysphagia Management Market To Move To “Growth Absorption” Spectrum Between 2019 to 2029 Tue, 19 Jan 2021 10:18:48 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684188.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684188.html persistencemarketresearch persistencemarketresearch The new report by Persistence Market Research (PMR) unveils that the worldwide revenue of  dysphagia management market  to reach  US $ ~ 3.5 Bn,  by the end of  2019 . It is projected that the business sector for dysphagia management is expected to grow at a healthy CAGR between 2019 and 2029, according to PMR's research report.

Expanding presence of managed care institutions, particularly in developed economies, is fueling the demand for neglected treatments such as dysphagia management. For instance, implementation of Affordable Care Act in the US has helped in successfully increasing insurance coverage because of which an increasing number of people are coming under the net of dysphagia management.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12988

Company Profiles:

  • Eisai Co. Ltd.
  • Becton, Dickinson and Company (BD)
  • AstraZeneca Plc.
  • Cipla Limited
  • Nestlé (Nestlé Health Science)
  • Kent Corporation (Kent Precision Foods Group, Inc.)
  • Danone (Nutricia Advanced Medical Nutrition)
  • Cook Group (Cook Medical Inc.)

According to the report, this factor majorly contributes in paving the way for growth of the dysphagia management industry by the end of 2029.

Increasing Number of Local Players Adding to the Competition in Dysphagia Management Landscape

Growing prevalence and rising demand for nasogastric tube and PEG tubes in primary dysphagia management have created an opportunity for local players to come with dysphagia management products at competitive rates. Apart from global market players such as Cook Medical Incorporation and Becton, Dickinson and Company, there are several other local players in the regional dysphagia management market across the globe that are catering to the local market.

For example, Dr. Goyal Medical Private Limited, OR Surgicals, NeoDevices, Inc and other small players are also participating in the dysphagia management market.

According to the PMR report, in distribution channel, hospital pharmacies will dominate the supply side in the dysphagia management market by the end of 2019. Following hospital pharmacies, retail pharmacies are next expected to harness maximum share in the forecast period of 2019-2029. This is due to the growing demand for dysphagia management products avenues in developed and emerging countries.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12988

A marked shift towards generic and OTC formulations from branded products has been noticed, owing to expiry of majority of blockbuster drugs in the dysphagia management market. Ease of manufacturing, availability of raw materials at low prices, and lower costs aiding the rapid market influx of generic drugs in lower income nations are creating growth opportunities for the dysphagia management market.

Opportunities Reside in Better Patient Compliance

According to the PMR study, Kent Precision Food Groups Inc., has setup guidelines for dysphagia diet, which state different levels of diet depending on the severity of the diseased state. These guidelines help the patient as well as the healthcare providers to have a better understanding of food selection in dysphagia management.

Major companies in the dysphagia management sector are putting efforts to meet the need of patients and healthcare personnel to get a drift in the dysphagia management market. Improving patient compliance is directly related to making diets more palatable. Companies are expected to perform better on devising innovations in taste masking.

This could lead to better patient compliance among pediatric and geriatric groups needing proper dysphagia management. Development of orodispersible tablets (ODTs) that can dissolve or disintegrate rapidly in the oral cavity could help in generation of higher revenues for players in the dysphagia management market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/12988

Other advantages of ODTs are no water is needed, no chewing is needed, improved stability, allows high drug loading, cost-effective and adaptable to existing processing and packaging machinery. Complying with these factors creates a tremendous growth opportunity for the competitors in dysphagia management sector.

Further, acceptance of such drugs among patient groups is also high due to cost effectiveness of the type of medication. Companies operating in dysphagia management are thus expected to largely benefit from development of palatable and cost-effective ODTs. PMR's analysis also demonstrates groundbreaking views on the business sector of the dysphagia management market along with insights on key business approaches and policies by competitors in the dysphagia management business.

]]>
The Elder Care Services Market To Ruffle Healthy Feathers Between 2025 Tue, 19 Jan 2021 10:18:26 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684187.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684187.html persistencemarketresearch persistencemarketresearch Global revenue of the  elder care services market  reached  ~ US $ 1 Bn in 2018 , disclosed the new research study by Persistence Market Research (PMR). According to the report, the institutional elder care services segment is expected to witness a  CAGR of ~ 8%  in the forecast period (2019-2029), primarily due to significantly including all nursing, medical clinic diagnostics and laboratory service, and other emergency room services.

Also, institution elder care services involve long term 24hour care service for medical and non-medical conditions. Home-based elder care services are associated with lower risk of re-hospitalization that results in increasing the business growth in the forecasted period as these care service include medical and non-medical care.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3427

Company Profiles 

  • Eldercare Services
  • Korian Group
  • ProVita International Medical Center, LLC
  • Home Instead, Inc
  • Living Assistance Services, Inc.
  • Benesse Style Care Co., Ltd
  • Econ Healthcare Group
  • Epoch Elder Care
  • St Luke’s ElderCare Ltd
  • India Home Health Care
  • Samvedna Senior Care
  • ApnaCare India Private Limited
  • Nichiigakkan Co. Ltd
  • Golden Years Hospital
  • Orange Valley Healthcare
  • NTUC Health Co-Operative Ltd
  • GoldenCare Group Private Limited
  • Carewell-Service Co., Ltd.
  • RIEI Co. Ltd.
  • SASCO Integrated Eldercare Centre
  • Cascade Healthcare
  • Millennia Personal Care Services
  • Rosewood Care Group Inc.
  • Pacific Healthcare Nursing Home
  • United Medicare Pte Ltd

Community-based elder care services are intended to provide care and companionship to geriatric population who require help or supervision.

The essential objectives of community-based elder care service centers are to postpone or avoid institutionalization, and to empower socialization among elderly that result in enhancing the revenue growth in the elder service care market.

The public expenditure segment captured the biggest share of the overall elder care services market in 2018 and was estimated around ~US$ 660 Mn. The government controls the cost of medicine, treatment, and therapeutic services through regulation and negotiation with the private insurers and hence subsequently eliminates the administrative cost, thereby driving market growth.

Private source for elder care services market is assessed to develop at an impressive CAGR of ~9% over the projection time frame.

Private insurance can be either directly purchased by the insurer or is offered by the organization to employees. Private insurance can be divided into hospital cover insurance or general treatment coverage insurance.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3427

The Demand for Home-based Elder Care Services at Pace

According to the PMR report, the worldwide market for elder care services, shows healthy development prospects for the market during the next ten years. Home-based elder care services are another common type of elder care services where a medical caretaker or other helper live full time in a senior’s home or spend a portion of the day in home watching out for the patient’s need.

The home-based elder care services segment is relied upon to develop  from ~ US $ 76 billion  in 2019 to ~ US $ 153 billion by the end of 2029 at a  CAGR of ~ 7%  in determined period, driven by an increasing geriatric population. Shortage of the US home health helpers and doctors, a booming senior population, and increasing prevalence of chronic diseases are the driving factors for the growth of home-based elder care services segment.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3427

Investments in Asia Pacific Widening Market Scope

Factors such as the expanding aging population, favorable infrastructure for elder care services in emerging economies, changing family structure, and increases awareness levels among the elderly population towards sound way of life is likely to drive the demand for elder care services in the Asia pacific region .

The developments in healthcare infrastructure, favorable reimbursement policies, and rising awareness are main reasons behind the established market in developed regions.

In contrast, elder care services provider is relatively low in developing regions such as Asia and Latin America, which represents scope of further introduction of elder care services provider in these regions.

Additionally, increasing healthcare spending, growing awareness among patients, rising number of older patients suffering from disabilities and chronic diseases, increase in the number of facility in developing countries are expected to result in major opportunities for key players in the elder care services market.

PMR's research analyzes that the Asia Pacific region for the elder care services market is expected to grow by an CAGR ~ 10% and around ~ 27%  of impressive  market share and opens new opportunities for key players to expand their revenue by entering this region.

]]>
The Global Scar Treatment Market To Witness A Growth-Wise Disruption Between 2019 to 2029 Tue, 19 Jan 2021 10:18:03 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684186.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684186.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) reveals that revenue generated from scar treatment product during financial year 2019 is approximately more  than US $ 10 Bn . According to the report published by PMR, reveals that the  scar treatment market  is anticipated to  show 1.4X growth  over the next decade owing to greater preference towards usage of specialized dermatology services.

This report by PMR points to the lack of standardization in the scar treatment landscape. The study reveals that there are no formalized guidelines for scar treatment, and most of them are recommended through word-of-mouth of expert clinicians and surgeons. However, efforts for the formalization of treatment guidelines, at least for common scars, still continue.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10819

Company Profiles:

  • Smith & Nephew PLC
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Rising Awareness about Personal Care Propelling the Demand

Scars, especially those on exposed parts of the body can adversely affect the appearance and may let down the self- confidence and consciousness of an individual. Consumers in the U.S. are more inclined towards new sophisticated scar treatment, such as lasers skin resurfacing, electrical stimulation, and derma fillers to maintain and further reduce scar appearance.

Expert plastic surgeons opine that a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, is increasingly resorting to advanced skin, scar, and dermatology services, thus, creating sufficient traction for scar treatment product manufacturers.

Rising awareness about personal care and wide availability of rhytides treatment and related products are among the major factors driving growth of the scar treatment market in North America and Europe.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10819

Patients Seek Quicker Results and Shortened Treatment Duration

Patients opting for scar treatment are increasingly adopting technologically advanced non-invasive or minimally invasive scar treatment procedures for achieving quicker and permanent results in a short time. To address this issue, physicians are gradually seeking more patient-involvement in the scar treatment formulation process.

For example, in developed countries, physicians prefer to explain the indication / s and different scar treatments that could help in curing them - to patients on the very first consultation appointment.

For example, a combination of inflammatory and non-inflammatory acne pimples could be best-cured using two topical medications - a retinoid and an antibiotic, an option for scar treatment. Managing patient expectation is a crucial attribute on part of both physicians and companies to deepen revenues.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/10819

Increasing Patient Involvement in Treatment Formulation Process

With heightened focus towards increasing patient safety and treatment efficacy, an increasing number of dermatologists in both the US and Canada are involving patient's opinion in the scar treatment formulation process.

This is being particularly noted for patients aged 13–25 years (teens to late teens), particularly for mild to deep acne scarring. In this regard collected, scar treatment adherence data over a period of 30 years from Global Alliance to Improve Outcomes in Acne Group reflected poor results while managing the acne regimen.

Deviations noted include self-medication, missing doctor appointment schedules, or both. These were directly a result of combination of multiple factors, including demographics, lifestyle, psychological / psychiatric issues, and environment.

Given these issues, physicians and clinicians have noted that greater patient involvement in therapeutic planning process along with increasing awareness of patients by imparting proper training have been proving highly effective with regard to positive outcomes for scar treatment.

]]>
The Neonatal Infant Care Market To Grow Seamlessly Between 2024 Tue, 19 Jan 2021 10:17:41 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684185.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684185.html persistencemarketresearch persistencemarketresearch Global revenue of the neonatal infant care equipment market reached  ~ US $ 1.7 Bn  in 2018, disclosed the new research study by Persistence Market Research (PMR). At present, various types of neonatal monitoring, assistance, and therapeutic care equipment are available commercially in  neonatal infant care equipment market .

However, penetration rate of these advanced neonatal infant care equipment has been slow in low- to medium-income countries.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/4157

Company Profiles

  • GE Healthcare
  • Koninklijke Philips NV
  • Medtronic plc.
  • Drägerwerk AG & Co. KGaA
  • Natus Medical Incorporated
  • Fisher & Paykel Healthcare Limited

The demand for neonatal infant care equipment has increased across geographies and owing to technological advancements along with improvements in the available neonatal infant care equipment, demand has been increasing significantly in both developed as well as emerging economies. Increasing demand for such equipment would contribute towards the overall growth of this market in the near future.

Thermoregulation Devices Contributing Substantial Revenue Shares

According to the report, the thermoregulation devices segment of the neonatal infant care market is expected to witness a CAGR of ~ 6% in the forecast period (2019-2029). Thermoregulation devices in neonatal infant care equipment market show a significant growth in the demand as these are the most important devices for the problem of hypothermia to new born sick infants. As per WHO, hypothermia is recognized as a significant contributor to neonatal morbidity and mortality for all new born infants.

Thermoregulation devices comprise of radiant warmers, which is expected to grow at a lucrative growth rate owing to its simple designed, economical, easy-to-clean, and easy- to-use by trained health workers. The major role of these devices is to keep infants warm in first aid emergencies or medical environments that require an appropriate temperature.

Despite the fact that incubators are considered as the most developed warming neonatal infant care equipment, it is more expensive and can increase the risk of infection. This is other factor that aid in development of thermoregulation devices.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4157

Manufacturers across the globe are developing thermoregulation devices, which are explicitly less priced and marketed for low-developing economies.

Hospitals registered a significant market share in the neonatal infant care equipment landscape in 2018, with revenues roughly equating US$ 919 Mn. There has been a considerable rise in the hospital investment by government across the globe to equip with the modern and technically advanced devices.

New and advanced neonatal infant care equipment are being used for taking care of hypothermic infants. Moreover, nursing homes, pediatric clinics, and neonatal clinics have also started to use neonatal infant care equipment.

Increasing Focus on Distribution Network  

According to the PMR report, market for neonatal infant care equipment is witnessing collaborative approach between companies and children hospitals, which is expected to boost the distribution network of companies in respective regions in order to benefit hospitals to access improved technologies.

Multinational companies such as GE Healthcare and Fanem Ltd. have signed strategic alliances with hospitals for supplying their neonatal infant care equipment to improve their distribution network in emerging markets.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/4157

Investments in Asia Pacific Point to Improving Scope for Penetration

Factors such as rising awareness about modern neonatal infant care equipment, increasing market share in low income nations, increasing number of preterm birth, and favorable infrastructure for neonatal infant care equipment in emerging economies are factors likely to drive the demand for neonatal infant care equipment in the Asia Pacific region.

The development in healthcare infrastructure, increase in the investment by the government, and rising awareness are main reasons behind the established market in developed regions. In contrast, neonatal infant care equipment provider is relatively low in developing regions such as Asia and Latin America, which represents scope of further introduction of neonatal infant care equipment provider in these regions.

A research study by Persistence Market Research (PMR) analyzed that the Asia Pacific region for the neonatal infant care equipment market is expected to  grow by CAGR ~ 7%  and around ~ 24 of market share and opens new opportunities for key players to expand their revenue by entering this region.

]]>
The Effervescent Products Market To Get Streamlined On A Healthy Front Between 2020 Tue, 19 Jan 2021 10:16:49 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684184.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/684184.html persistencemarketresearch persistencemarketresearch Worldwide sales of breast implants is expected to  reach ~ US $ 1.8 Bn  by the end of  2019  and is forecasted to  reach ~ US $ 1.7 Bn  by the end of  2029 , unveils the new research study by Persistence Market Research (PMR). According to the report, the  breast implants market  is estimated to grow  by ~ 3%  YOY by the end of 2020, primarily influenced by the recent advancements in the breast implants market.

According to the report, greater emphasis on physical appearance of the breasts and rise in global per capita disposable income of women have led to more number of women undergoing breast implants procedures globally. Also, manufacturers of breast implants are focusing on introducing wide range of breast implants in terms of sizes, shapes, and texture, which is expected to upsurge the growth of the global breast implants market over the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10972

Company Profiles

  • Allergan, Plc (Actavis Plc)
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Combined Breast Augmentation to Create Scope for the Market Growth

Breast augmentation procedures in combination with breast lifting have received much attention among women in recent years to enhance the appearance of their breasts in terms of shape and size particularly those who are concerned with deflated or sagging breast appearance. While a breast lift procedure will elevate and reshape breasts, breast implants will add volume to their breasts.

Also combined procedural cost is less when compared to the individual procedure leading to more number of women opting for both procedures at one time. These factors are anticipated to aid the growth of the breast implants market over the forecast period.

Strong Distribution Network to Drive the Breast Implants Market

Strong distribution network is one of the prime factors responsible for the growth of the global breast implants market. Various major implants manufacturers are undergoing distribution agreements in order to make their products available resulting in deep penetration of aesthetic services across low income countries.

Thus, easier availability of products and increasing demand for breast implants products globally, is contributing to the overall growth of the breast implants market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10972

Greater Emphasis on Physical Appearance is a Factor Fueling the Market Growth

Greater emphasis on aesthetic appearance is the main factor fueling revenue growth of the breast implants market globally. A large number of women are conscious about the physical appearance of their breasts leading to increasing number of breast augmentation procedures in developed countries such as North America and Europe.

However, some of the most common reasons for breast augmentation procedures include changing the breast size, restoring natural appearance of breasts, and correcting capsular contracture.

Also, women are increasingly spending on cosmetic surgical procedures to enhance their physical appearance and the number is expected to rise significantly over the next few years.

According to the US-based National Institute of Aging and American Academy of Plastic Surgeons, a significant share of the population in the US, primarily within the age group of 18-30 years and onwards, are increasingly resorting to advanced aesthetic services including breast implants thus, creating sufficient traction for manufacturers in the breast implants market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/10972

Composite Breast Augmentation to Boost Patient Base for Breast Implants

Composite breast augmentation combines the ability of a breast implants to provide increased volume of breasts with reshaping capabilities offered by fat grafting technique. The technology together provides more versatility, especially in women who are more concerned about animation deformities and patients who are athletic. The technique is expected to have a major influence on the breast implants market globally over the next few years.

]]>
The Bioabsorbable Implants Market To Move Away From Stagnation, Reach US$ XX Million Mon, 18 Jan 2021 10:45:16 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683956.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683956.html persistencemarketresearch persistencemarketresearch Technological improvements and preferences in  bioabsorbable Implants  in recent decades have resulted in wide range of applications and better outcomes which are predicted to contribute to the growth of global bioabsorbable Implants. The launch of new products in the market, brings in new technology which eases treatment procedures and provides improved results to patients.

Manufacturers on a global level are engaging in developing products which should get recognition in order to be in use. Bioresorbable implants have been used for the fixation of facial bones offering various advantages over titanium plates by reducing the need for a second operation for their removal.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/28057

Company Profiles:

  • Meryl Life Sciences Pvt. Ltd.
  • Medtronic Plc
  • Smith & Nephew Plc
  • Stryker Corporation
  • Wright Medical Group
  • KLS Martin
  • BIOTRONIK Ltd
  • Syntellix AG
  • Q3 Medical Devices Limited.
  • JW Medical Systems LTD
  • ORBUSNEICH MEDICAL.

Bioabsorbable implants are used for treating, knee hands, and wrist injuries moreover the bioabslorbable implants are used successfully in reconstruction and repair of many extra and intra articular abnormalities in the shoulders such as rotator cuff tears.

Also bioabsorbable implants are used for spinal reconstruction surgeries, for instance PLA screws are used for fusion procedures and cervical decompression. PLLA pins are used in lumbar spine which improve the mobility.

Significant collaboration efforts among key players in the medical industry, and presence of reimbursement agencies will further aid the growth of the market. Owing to the dissolving nature of the bioabsorbable implants and faster results, the bioabsorbable implants space has been witnessing modest growth in recent years.

Get To Know Methodology of Report @  https://www.persistencemarketresearch.com/methodology/28057

Increasing prevalence of patients suffering from osteoarthritis leading to knee fracture, among the population is increasing the growth of bioabsorbable Implants market. Almost 260,000 Americans suffer and require surgeries. Presence of large patient pool suffering from Pelvic organ prolapse is expected to drive the growth of the transvaginal Bioabsorbable Implants and meshes in the market during the forecast period.

The bioabsorbable Implant companies are significantly collaborating and acquiring among the key players in the industry, reimbursement agencies are further aiding the growth of the market. The company DePuy Synthes Acquired Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects with which the company is aiming to create patient-specific, bioresorbable implants

Bioabsorbable Implants market is fragmented in nature with the distributors of the b ioabsorbable Implants market in different parts of the world. The bioabsorbable implants companies operating in the market are focusing on launching better and advanced products to further increase sensitivity and better outcomes to avoid side effects which would further increase the adoption rate of the bioabsorbable implants in the future.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/28057

However, side effects and complications such as allergies, inflammations, drug reactions resulting in organ and system failure is expected to negatively impact the growth of the global Bioabsorbable Implants market over the forecast period.

According to the report, the fixation devices implants accounted for over 40% revenue share in the global bioabsorbable Implants market in 2017.

Moreover, the advancements in the technology is creating awareness and popularity of Bioabsorbable Implants in the market which is further increasing, the growth of other segment of Bioabsorbable Implants in the near future.

]]>
The Fibrinogen Testing Market To Witness A Stunning Progression, Reach US$ XX Million Mon, 18 Jan 2021 10:44:54 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683955.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683955.html persistencemarketresearch persistencemarketresearch The fibrinogen testing reagents market observes a dynamic nature of consumer preference for each product as part of their operating instrument. Though, there have been no significant technological advancements in the development of reagents since many years now. The applications and usage still remain the same, but the influx of new manufacturers in the fibrinogen testing reagents market surely assures a much more competitive market space than it currently is.

There are several factors for the fibrinogen testing reagents market to grow in the coming years, as bleeding conditions in the US, followed by India and China, are expected to contribute to the largest consumer base for fibrinogen testing reagents.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/5420

Company Profiles:

  • Thermo Fisher Scientific Inc.
  • Grifols
  • Helena Laboratories Corporation
  • Stago
  • TULIP DIAGNOSTICS (P) LTD
  • Werfen
  • Biosystems S.A.
  • Randox Laboratories Ltd.
  • Technoclone
  • Medirox AB
  • MedTest
  • Enzyme Research Laboratories(r2 Diagnostics)
  • Kamiya biomedical Company
  • Pathway Diagnostics Limited

According to the latest research by PMR, the global fibrinogen testing reagents market is estimated to have accounted for US$ 116.3 Mn in terms of value during 2017. The report on the fibrinogen testing reagents market further projects that, the market is likely to grow at a CAGR of 8.9% during the forecast period 2018-2028.

Rising Preference for the Convenience of Online Services Favoring Sales of Fibrinogen Testing Reagents

An increase in the online sale of products and ordering of online tests have positively impacted the growth of the global fibrinogen testing reagents market. Several laboratories offer online services, wherein, patients can order their desired tests, while the testing is taken care of by a laboratory. The adoption rate of online services is higher in countries such as the UK and the US. Such differences lead to a better market space for fibrinogen testing reagents.

Also, a rise in the awareness among people about blood condition diseases has led to an increase in acceptance of disposable products. Parallel influences of diagnostic consumables have a positive impact on the overall fibrinogen testing reagents market.

The fibrinogen kits segment is the leading segment in terms of revenue, by reagent type, in the fibrinogen testing reagents market, registering a 71.4% revenue share in 2017. After fibrinogen kits, the multifibren U reagents and omidazole buffer kits are expected to follow in the fibrinogen testing reagents market, by reagent type.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5420

Fibrinogen testing reagents are most widely used for the diagnosis of end-stage liver disease. The end-stage liver disease segment, by indication, is thus expected to dominate the fibrinogen testing reagents market in term of revenue over the forecast period of 2018-2028. Among all end users in the fibrinogen testing reagents market, the hospitals segment is the most lucrative segment, and this is followed by the diagnostic laboratories segment.

East Asia Likely to Emerge Lucrative for Fibrinogen Testing Reagents Market

While Europe has been a prominent regional market for fibrinogen testing reagents, followed by North America, the former will maintain a significant revenue share of nearly a third of the fibrinogen testing reagents market. and is estimated to have registered a revenue share of 31.4% in 2017.

The report has cited East Asia as an attractive region for fibrinogen testing reagents market players. South Korea, South Africa, and Russia are some of the lucrative countries reflecting high growth potential for the fibrinogen testing reagents market, according to the report. South Korea has been projected as one of the fastest thriving markets for the global fibrinogen testing reagents.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/5420

Leading Players in Fibrinogen Testing Reagents Market Strategizing on Expansion in Emerging Regions

A majority of key players are reportedly focusing on increasing their shares in South Asian and Latin American markets for fibrinogen testing reagents via strategic mergers and acquisitions involving recognized regional players and investment groups. On the other hand, regional players in the fibrinogen testing reagents market are focusing on entering long-term contractual relationships with direct end users to be able to sustain continuous revenue flow.

]]>
The Cardiac Marker Analyzer Market To Slither Amidst Covid-19, To Pick Up Pace Post-Covid-19, Reach US$ XX Million Mon, 18 Jan 2021 10:44:31 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683954.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683954.html persistencemarketresearch persistencemarketresearch Global demand for cardiac marker analyzers is projected to witness  over 4.5% year  on year growth in 2019. As indicated by Persistence Market Research in a newly published research intelligence study, North America remains the top consumer market for cardiac marker analyzers manufacturers, and the region's market value is projected to cross  US $ 285 million in 2019 .

Expanding Geriatric Population and Obesity

Nearly 17% of the global population will be above 65 years of age by the end of 2050, as projected by NIH (National Institutes of Health). Whereas, WHO (World Health Organization) indicates that around 13% of the worldwide population is currently suffering from obesity. While both the aforementioned factors intersect at a higher risk of acquiring cardiovascular diseases, it is more likely that the adoption of cardiac market analyzers will be on the rise in coming years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3479

Company Profiles

  • Siemens AG
  • Radiometer Medical
  • Abbott Laboratories
  • Quidel Corporation
  • Beckman Coulter, Inc.
  • Boditech Med Inc.
  • F. Hoffmann-La Roche Ltd
  • Creative Diagnostics
  • Others.

Disease Management

The growing need for early detection of rapidly prevailing CVDs such as myocardial infarction and angina pectoris is likely to push prospects for cardiac marker analyzers in the near future. A rising trend of individualized treatment and real-time results targeting early patient diagnostics is playing a crucial role popularizing the demand for cardiac marker analyzers.

With ascending significance of disease management, the devices that help manage the disease progression rate are gathering significant momentum in recent years – subsequently encouraging sales of cardiac marker analyzers.

Laboratory diagnostics are identified to hold promising opportunities for manufacturers based on developing economies such as India, China, Brazil, and Japan. These emerging markets are projected to remain highly attractive owing to the briskly progressing R&D platform.

Drug Development Related Opportunities

Growing use of cardiac marker analyzers in drug development as well as lab diagnostics continues to stimulate innovation and adoption, indicates the report.

“Visibly growing preference for Troponin over other conventional markers in diagnosis of heart attack is the key trend shaping the revenue growth of cardiac marker analyzers landscape,” explains the analyst at the company. Adding further, “The remarkable inadequacy in existing drug development processes for CVDs is another strong factor broadening the scope for penetration of cardiac marker analyzers at a global level,” says the analyst.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3479

Competition Tracking

While around 80% share of the global revenue through sales of cardiac marker analyzers belongs to the top industry players, the rest is covered by a number of smaller companies that currently operate at a local or regional level. Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Siemens AG, and a few others are thoroughly profiled in the PMR report.

Abbott acquired St. Jude Medical the last year, with an objective to reap benefits of the latter's strong global position in thriving cardiac areas such as heart failure, atrial fibrillation, structural heart, and chronic pain complement.

Earlier this year, Beckman Coulter Inc. (Danaher Corporation) received the clearance approval by Health Canada for the new high-sensitivity troponin (hsTnI) assay. More recently, Siemens AG launched the Troponin test kit that has been a key marker used diagnosing heart attack.

Besides M&A, strategic collaborations with local distributors, suppliers, wholesalers, and retailers is also likely to remain one of the key strategies of competitors in cardiac marker analyzers landscape. Several leading companies are also signing contractual agreements with channel partners such as associations and universities over the manufacturing of cardiac market test kits.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3479

North America and Europe Remain Top Markets

At an estimated 5% yearly growth in 2019, North America remains the top performing market for cardiac marker analyzers. While chemiluminiscence immunoassay (CLIA) analyzers account for more than 30% share of the region's total revenue, whereas diagnostic centers continue to make up for over half of the market value of the region. Enzymeimmunoassay (EIA) analyzers are however projected for highly attractive investment opportunities in coming years.

Europe's market, the second largest consumer of cardiac marker analyzers, is predominantly driven by chemiluminiscence immunoassay (CLIA) analyzers, followed by MICA analyzers ie presumably the most lucrative segment for key players.

]]>
The Confocal Microscope Market To Show Constructive Disruption With US$ 1,310.5 Million Mon, 18 Jan 2021 10:44:09 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683953.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683953.html persistencemarketresearch persistencemarketresearch According to the latest market report published by Persistence Market Research titled 'Global Confocal Microscope Market: Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2028,' the global confocal microscope market is projected to reach  US $ 1,310.5 Mn  by the end of  2028  and grow at a  CAGR of 3.3%  during the forecast period.

Global Confocal Microscope Market: Dynamics

Confocal microscope is a special form of standard fluorescence microscope. Confocal microscopy is different from the conventional wide field fluorescence microscopy, in which the optical path is designed to place in front of the image detector (photomultiplier tube or camera), and an aperture (opening) at a point where the image is focused in conjunction with the focal plane of the image.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/16174

Company Profiles

  • Olympus Corporation
  • Leica Microsystem (Sub. Danaher)
  • ZEISS Group (Carl Zeiss Meditec AG)
  • Nikon Corporation
  • Bruker Corporation
  • Bio-Rad Laboratories, Inc
  • Oxford Instruments plc
  • Thorlabs, Inc.
  • Confocal.nl
  • ISS.Inc
  • Others.

Government policies and funding for biological research activities and shift towards value-based care are the major factors expected to drive the growth of the market for confocal microscope over the forecast period.

Furthermore, increasing number of research and development activities and technological advancement in microscopy are the other factors expected to spur the growth of the market for confocal microscope over the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/16174

Increasing spending on research & development and emergence of academia as the primary organization for carrying out basic research will further increase the adoption rate of confocal microscope. Likewise, use of confocal microscope for live cell imaging and confocal microscopy in ophthalmology is also expected to drive the growth of the market for confocal microscope.

However, high cost of technologically advanced microscopes and shortage of skilled professionals and expertise are expected to hamper the growth of the Confocal Microscope market.

Global Confocal Microscope Market: Forecast

The global confocal microscope market is segmented on the basis of product type, and end user. On the basis of product type, the global confocal microscope market is segmented into microscope system, accessories and software. Microscope system is sub segmented into laser scanning confocal microscope, spinning disk confocal microscope and re scan microscope.

The microscope systems is expected to be the leading segment in the global confocal microscope market over the forecast period. The microscope systems accounts a total value share of 92.0% of the global confocal microscope market in 2017. The laser scanning confocal microscope segment is estimated to have incremental opportunity of US $ 200.1 Mn between 2016 and 2028.

Among end user, academic & research institute segment is expected to hold high share in the global confocal microscope market owing to increasing number of research in life science applications and rising adoption of confocal microscope in academic research.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/16174

Geographically, the global confocal microscope market has been segmented into North America, Latin America, Europe, Asia Pacific, Japan and Middle East & Africa. This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the confocal microscope market in specific regions.

North America accounted a large share in the global market in 2017, and is expected to be the dominant regional market for confocal microscope over the forecast period, owing to increasing spending in research and development.

Besides, the presence of several key players with a robust distribution network for microscope and collaboration for the development of new techniques are some of the other key factors expected to drive the growth of the confocal microscope market in North America. Asia Pacific is expected to witness rapid growth over the forecast period.

]]>
The Humanized Liver Mice Model Market To Flicker Amidst Covid-19, Reach US$ 22.8 Million Mon, 18 Jan 2021 10:43:46 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683952.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683952.html persistencemarketresearch persistencemarketresearch A large number of humanized liver mice models are available, including uPA-SCID mice, FRG KO mice, and TK-NOG mice, among others. Factors such as increasing incidence of liver cirrhosis, technological advancement and development of new humanized liver mice models, increase in number of FDA approvals for liver-based disease treatment dugs have increased the number of research and development activities, which require these models.

However, the high cost of mice models as well as high shipping cost, and availability of alternatives are factors expected to hinder the growth of the humanized liver mice model market during the forecast period. Furthermore, regulatory challenges including patenting of mice and other ethical issues including the use of 3Rs policy are also expected to restrain the growth of the humanized liver mice model market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/25417

Company Profiles

  • Taconic Biosciences, Inc.
  • Beijing Vitalstar Biotechnology Co., Ltd.
  • Yecuris Corporation
  • PhoenixBio Group
  • In-Vivo Science Inc.
  • The Jackson Laboratory
  • University of Massachusetts Medical School(Mueller Lab)
  • Oncodesign
  • University of Nebraska Medical Center
  • Others.

The global humanized liver mice model market is projected to account for over US$ 22.8 Mn in terms of value by 2026 end, according to a latest research by PMR. The report on the global humanized liver mice model market further projects significant growth potential with average year-on-year growth rate of 4.6% through 2026.

Albumin enhancer/promoter-driven urokinase-type plasminogen and activator/severe combined immunedeficient mice are known as the uPA-SCID mice. These mice suffer from a transgene-induced liver disease, and are transplanted with primary human hepatocytes immediately after birth.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/25417

These mice were one of the first humanized liver mice model developed with high chimerism and are the most common type of humanized liver mice models available. The TK-NOG mice are designed to express a Herpes Simplex Virus-1 Thymidine Kinase (HSVtk) transgene that is primarily driven by the albumin enhancer/promoter in the liver of the mice. This induces liver-specific injury when treated with gancyclovir.

Human liver cells are then introduced into the liver of the mouse to replace the liver cells that are destroyed. The other type of humanized liver mice model that is gaining popularity is the FRG KO mice. The FRG KO mice are developed by knocking out three genes including Fah-/-; Rag2-/-; and Il2rg-/-.

These mice overcome some of the drawbacks of the uPA-SCID mice such a low breeding capacity and genotype reversion. These mice have a slightly better breeding capacity and cannot undergo genotype reversion allowing the human hepatocytes to be serially transplanted into other mice. These humanized liver mice models also show high chimerism like the uPA-SCID mice.

PMR has segmented the global humanized liver mice model market based on model, application, end user and region. The humanized liver mice model by model is further sub-segmented into uPA-SCID Mice, FRG KO Mice, TK-NOG Mice, and other models. Based on end users, the humanized liver mice model market is segmented into pharmaceutical companies, biotechnology companies, CRO's and academic & research institutes.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/25417

CRO's segment is expected to hold maximum share in the global humanized liver mice model market followed by academic & research institutes segment. Based on application, the humanized liver mice model market is segmented into pharmacokinetic studies, in-vivo liver toxicity testing, drug metabolism studies, and other applications.

North America is expected to be the dominant regional market for humanized liver mice model. This is due to the support for research activities by the government as well as private sectors.

Government funding and support for patenting genetically modified mice are other factors that support the growth of the humanized liver mice model market in North America. China is also expected to be a lucrative regional market for humanized liver mice model due to the changing regulations of the government to support the pharmaceutical and biopharmaceutical industries in the region.

]]>
The Sarcopenia Treatment Market To Witness A Slump, Reach Merely US$ 3,302.0 Million Mon, 18 Jan 2021 10:43:24 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683951.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683951.html persistencemarketresearch persistencemarketresearch According to the latest market report published by the company titled ' Sarcopenia Treatment Market : Global Industry Analysis 2013 - 2017 and Forecast, 2018 - 2026,' the global sarcopenia treatment market is projected to reach  US $ 3,302.0 Mn  by the  end of 2026  and grow at a  CAGR of 4.2%  during the forecast period.

Global Sarcopenia Treatment Market: Dynamics

Sarcopenia is categorized by progressive and generalized loss of skeletal muscle mass and strength, with a risk of adverse outcomes such as poor quality of life, physical disability and death. Sarcopenia is the age-related loss of muscle mass, after the age of 60 the muscle mass declines at an annual rate of 1.5% to 3.0% per year. The prevalence of sarcopenia among people aged 65 years and above is estimated to be 15%, whereas 50% among people aged 80 and above.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15694

Company Profiles

  • Abbott Laborites
  • Pfizer Inc.
  • Novartis AG
  • GlaxoSmithKline Plc.
  • Nestlé S.A.
  • Bayer AG
  • Sanofi S.A.
  • Amway
  • Cadila Healthcare Ltd.
  • Eli Lilly and Company
  • Others.

Increasing consumption of dietary and nutritional supplements due to health consciousness among the elderly population is expected to propel the demand for sarcopenia treatment. The benefits of nutritional supplements to overcome vitamin deficiency is expected to boost the growth of the sarcopenia treatment market.

Most of the pharmaceutical and food-processing companies are investing in the development of new nutrition supplements in order to focus on the specific needs. Likewise, increasing investments in nutraceutical development is the major factor expected to spur the growth of the sarcopenia treatment market.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/15694

The growth of the sarcopenia treatment market is primary driven by the increasing aging population. According to the National Institutes of Health (NIH), the global population of people aged 80 and above is expected to grow from 126.5 million to 446.6 million between 2015 and 2050.

Reduction of hormone secretion rate and increasing vitamin deficiency with aging are expected to create high demand for sarcopenia treatment supplements. Economic factors such as the rise in consumer spending by the aging population and increasing per capita healthcare expenditure are also expected to drive the demand for sarcopenia treatment supplements.

According to the National Health Expenditure Accounts (NHEA), the U.S. health care spending grew by 4.3% in 2016, reaching US$ 3.3 trillion or US$ 10,348 per person.

However, the diagnosis rate of sarcopenia is very low as a large number of people ignore the symptoms of muscle loss. Moreover, low awareness regarding diagnostic and management methods of sarcopenia due to lack of skilled professionals is expected to hamper the growth of the sarcopenia treatment market.

Moreover, unavailability of sarcopenia treatment drugs and the high cost of protein supplement are the other factors expected to restrain the growth of the sarcopenia treatment market.

Global Sarcopenia Treatment Market: Forecast

The global sarcopenia treatment market is segmented based on treatment type, distribution channel, and region. Based on treatment type, the global sarcopenia treatment market is segmented into protein supplement, vitamin D & calcium supplement, and vitamin B12 supplement.

The protein supplement segment is expected to represent a high revenue share in the global sarcopenia treatment market over the forecast period.

Based on the distribution channel, the global sarcopenia treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and hypermarket & supermarket. Among all the distribution channels, the retail pharmacies is expected to be the leading segment in the global sarcopenia treatment market over the forecast period.

The online pharmacies segment is expected to represent a high growth rate in the global sarcopenia treatment market due to increasing online purchasing and manufacturer's inclination towards digital platforms for marketing and sale.

On the basis of region, the global sarcopenia treatment market has been segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.

This report assesses the trends driving the growth of each segment and offers analysis and insights into the potential of the sarcopenia treatment in specific regions. North America is expected to contribute a high revenue share in the global sarcopenia treatment market over the forecast period.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/15694

The demand for sarcopenia treatment has increased in North America due to the increasing adoption of nutritional supplements, particularly by the elderly population due to increasing health consciousness. Europe is expected to account second large share in the global sarcopenia treatment market over the forecast period.

The developed European countries, such as Germany, the UK, France, and Italy, are expected to account high share in the Europe sarcopenia treatment market due to increasing sarcopenia prevalence associated with inactive lifestyle and obesity. The Asia Pacific is expected to witness rapid growth in the global sarcopenia treatment market over the forecast period due to increasing aging population in countries such as Japan.

]]>
The National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies. Fri, 15 Jan 2021 10:59:44 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/abruzzo/683713.html Automotive Market Research Reports Automotive Market Research Reports Top impacting factors: Market Scenario Analysis

The ever rising prevalence of several infectious and chronic diseases like cancer, diabetes and arising health problems like depression, stress, lack of sleep and mental disturbance especially in the upcoming generation due to various factors like change in lifestyle is expected to boost the growth of CBD hemp oil market in coming years. Further, the use of hemp oil in numerous forms like spray, tincture and vape especially in the developed and developing economies is one of the major causes that would help the CBD hemp oil market growth. Its wide range of application against diverse diseases and various health benefits related with it such as pain relief, reduction in anxiety and depression, proven benefits when used as a topical ointment for treating skin problems and neuroprotective attributes results in increasing demand for CBD hemp oil all over and is expected to drive the growth of the market.

Due to recent studies and subsequent research of various CBD substances brought to notice the importance of CBD hemp oil in medical industry. In 2017, the National Institute of Health backed around 330 projects with $ 140 million spent on cannabinoid and related studies.

Companies covered:

Cannavest, Pharmahemp, ENDOCA, BAFA Gmbh, Protect Pharma, Rakitovica, Biobloom Hemp, DragonflyCBD, MH medical hemp GmbH, Elixinol.

According to a report published by World Health Organization, CBD shows no significant results indicative of any abuse or dependence potential. As of now, there is no significant evidence of side effects associated with the use of CBD. Presence of a compound called Delta-9 tetrahydrocannabinol in the oil, is proving significant as it has shown positive outcomes when applied in stress relief and maintaining the body’s general state of balance.

Geographies covered:

  • North America (U.S., Canada, Mexico)
  • Europe (France, Germany, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

However, prohibition for the use of CBD in some countries, the strict regulations regarding use of CBD hemp oil, complex administrative formation for the acceptance of hemp on a large scale and the scarcity of procurement of seeds for agricultural utilization of hemp are some circumstances which can restrain the growth of CBD hemp oil market. In order to overcome these hindrances, the key players in the market are coming up with various innovative solutions and the implementation of these solutions in the current industry scenario along with expansion policies in potential markets in the Asian region can be an important opportunity to grow the CBD hemp oil market.

Key benefits of the report:

  • This study presents the analytical depiction of the global CBD hemp oil industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global CBD hemp oil market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global CBD hemp oil market growth scenario.

North America Emerges as the Largest Market for CBD Hemp Oil

Legalization of marijuana countries like the United States, increasing usage due to rising awareness of the health benefits of CBD Hemp oil, North American region is predicted to have immense growth with highest market share in the global market. The presence of industry players in the region is also having a promising impact on the market growth. Furthermore, the heavy funding for R&D activities and well-developed healthcare infrastructure are fueling the market growth for CBD hemp oil.

]]>
The Flavors Into Over The Counter OTC Pharmaceuticals Market To Be Resplendent At A CAGR Of 7% Fri, 15 Jan 2021 08:54:33 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683684.html persistencemarketresearch persistencemarketresearch Preference for fruit flavors in medicines is an ongoing trend in the  flavors into over-the-counter (OTC) pharmaceuticals market . The consumption of fruit flavor formulations by leading manufacturers is relatively high as compared to other flavors.

Strong consumer preference for fruit flavors has prompted manufacturers of OTC pharmaceuticals to develop unique formulations using them.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/30665

Company Profiles:

  • Givaudan SA
  • International Flavors & Fragrances Inc.
  • Kerry Group
  • Sensient Technologies Corp.
  • GOLD COAST INGREDIENTS, INC.
  • Prinova Group LLC.
  • Carmi Flavor and Fragrance Co. Inc.
  • AromataGroup srl
  • Marc Flavors
  • Quest Nutra Pharmaceuticals
  • Sapphire Flavors & Fragrances
  • TASTE MASTER FLAVORS PVT LTD.
  • Virginia Dare
  • Concept Flavours & Fragrances Pvt. Ltd.
  • Flavor & Fragrance Specialties

Fruit flavors such as pineapple, strawberry, cherry and orange are mostly preferred flavors for pharmaceuticals. The adoption of flavored pharmaceuticals, especially in medicines for kids, is increasing because of the taste masking effect of these medicines.

Citrus and lemon flavors, followed by fruit flavors, are commonly used by formulators of pharmaceuticals.

Lemon and mint flavors are generally preferred in chewable tablets or gums. Vanilla or other dairy-based flavors are the least preferred flavors, used in medicines.

PMR has also found that the adoption of flavored medicines, among geriatric patients is lesser as compared to those for pediatric patients.

Outsourcing and Industrial Consolidation – Key Winning Imperatives

The report states that the companies manufacturing OTC pharmaceuticals typically focus on volume, and hence have been shown to be involved in several industrial collaborations. Key players in the flavors into over-the-counter (OTC) pharmaceuticals market are focusing on entering into strategic collaborations and acquisitions of companies operating in related industry to strengthen their position and extend their global reach.

For Example, in 2018, Sensient Technologies Corp. completed the acquisition of Mazza Innovation Limited, a botanical extraction business with patented solvent-free extraction processes, located in Vancouver, Canada.

Similarly, in 2017, International Flavors & Fragrances Inc. acquired “David Michael”, a privately held flavor company. Through this acquisition, International Flavors & Fragrances, Inc. strengthened its flavor market position in North America.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/30665

Tapping into Opportunities in Developing Countries

Most of the pharmaceutical players are focusing on developing markets, due to the stagnation of the major markets and presence of a large number of local manufacturers, especially in developing countries.

Changes in disease pattern caused due to changes in the lifestyle, increase in disposable income, improved access to healthcare services, and increasing demand for high-quality healthcare make these markets highly profitable for pharmaceutical companies.

However, this trend is currently opposite in developed economies with sophisticated manufacturing practices, where demand for superior quality excipients is increasing.

An increase in the adoption of continuous processing of excipients, is also an ongoing trend in flavors into the over-the-counter (OTC) pharmaceuticals market. Continuous processing of excipients refers to flow production of the raw material without any kind of interruption.

Manufacturers Target towards Production Capacity Expansion

Over the past few years, major pharmaceutical companies have been expanding their external and internal capacity in production.

Outsourcing opportunities arise in all innovator, generic, as well as other markets for OTC medications.

Even though manufacturing technologies for OTC medications have rapidly matured in the past two decades, the manufacturing of low-margin OTC generics requires the usage of old technologies.

While major pharmaceutical companies are investing resources on newer technologies, the manufacturing of generic OTC drugs and branded over-the-counter drugs is being outsourced.

South Asia & East Asia Remain Prominent Markets

South Asia and East Asia are expected to show significant growth of the flavors in over-the-counter (OTC) pharmaceuticals market. A large portion of the population of Asia remains undertreated, majorly due to the unavailability of effective prescribed drugs, and this is providing growth opportunities for the flavors into over-the-counter (OTC) pharmaceuticals market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/30665

Low Awareness and Poor Availability of OTC Drugs to Hinder the Market Growth

Lack of awareness about the flavors into OTC pharmaceuticals, especially in the developing economies, continues to create a hindrance in the market growth.

Poor availability of drugs at hospital pharmacies and retail pharmacies can be responsible for decreasing the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market. Also, the marketing of OTC pharmaceutical products requires skilled, trained and knowledgeable pharmacists. A lack of skilled and trained pharmacists, especially in the developing regions, can hinder the overall growth of the flavors into over-the-counter (OTC) pharmaceuticals market.

]]>
The Global Scar Treatment Market To Grow At A Splendid CAGR Of 3% Fri, 15 Jan 2021 08:54:10 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683683.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) reveals that revenue generated from scar treatment product during financial year 2019 is approximately more  than US $ 10 Bn . According to the report published by PMR, reveals that the  scar treatment market  is anticipated to  show 1.4X growth  over the next decade owing to greater preference towards usage of specialized dermatology services.

This report by PMR points to the lack of standardization in the scar treatment landscape. The study reveals that there are no formalized guidelines for scar treatment, and most of them are recommended through word-of-mouth of expert clinicians and surgeons. However, efforts for the formalization of treatment guidelines, at least for common scars, still continue.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/10819

Company Profiles:

  • Smith & Nephew PLC
  • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
  • GC Aesthetics plc
  • Sientra, Inc.,
  • Groupe Sebbin SAS
  • Polytech Health & Aesthetics GmbH
  • Establishment Labs S.A.
  • HansBiomed Co., Ltd
  • CEREPLAS

Rising Awareness about Personal Care Propelling the Demand

Scars, especially those on exposed parts of the body can adversely affect the appearance and may let down the self- confidence and consciousness of an individual. Consumers in the U.S. are more inclined towards new sophisticated scar treatment, such as lasers skin resurfacing, electrical stimulation, and derma fillers to maintain and further reduce scar appearance.

Expert plastic surgeons opine that a significant share of the population in the U.S., primarily within the age group of 18-30 years and onwards, is increasingly resorting to advanced skin, scar, and dermatology services, thus, creating sufficient traction for scar treatment product manufacturers.

Rising awareness about personal care and wide availability of rhytides treatment and related products are among the major factors driving growth of the scar treatment market in North America and Europe.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/10819

Patients Seek Quicker Results and Shortened Treatment Duration

Patients opting for scar treatment are increasingly adopting technologically advanced non-invasive or minimally invasive scar treatment procedures for achieving quicker and permanent results in a short time. To address this issue, physicians are gradually seeking more patient-involvement in the scar treatment formulation process.

For example, in developed countries, physicians prefer to explain the indication / s and different scar treatments that could help in curing them - to patients on the very first consultation appointment.

For example, a combination of inflammatory and non-inflammatory acne pimples could be best-cured using two topical medications - a retinoid and an antibiotic, an option for scar treatment. Managing patient expectation is a crucial attribute on part of both physicians and companies to deepen revenues.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/10819

Increasing Patient Involvement in Treatment Formulation Process

With heightened focus towards increasing patient safety and treatment efficacy, an increasing number of dermatologists in both the US and Canada are involving patient's opinion in the scar treatment formulation process.

This is being particularly noted for patients aged 13–25 years (teens to late teens), particularly for mild to deep acne scarring. In this regard collected, scar treatment adherence data over a period of 30 years from Global Alliance to Improve Outcomes in Acne Group reflected poor results while managing the acne regimen.

Deviations noted include self-medication, missing doctor appointment schedules, or both. These were directly a result of combination of multiple factors, including demographics, lifestyle, psychological / psychiatric issues, and environment.

Given these issues, physicians and clinicians have noted that greater patient involvement in therapeutic planning process along with increasing awareness of patients by imparting proper training have been proving highly effective with regard to positive outcomes for scar treatment.

]]>
The Urinary Catheters Market To Leave Behind Presumptions With An Estimated CAGR Of 4.1% Fri, 15 Jan 2021 08:53:48 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683682.html persistencemarketresearch persistencemarketresearch Global revenue of urinary catheters reached ~  1.5 billion  in 2018, unveils the new research study by Persistence Market Research (PMR). According to the report,  the urinary catheters market  is estimated to grow  by ~ 4% YOY in 2019 , primarily attributed to ease of use, cost effective nature, reduced risk of urinary tract infection, and increase in demand as it is an effective solution among patient population.

Intermittent urinary catheter is gaining a great deal of footing in the market, as intermittent catheterization remains the first and safer method of choice. This urinary catheter does not have many contraindications and permits typical bladder elements. The single-use intermittent urinary catheter is most favored for intermittent catheterization, as it is advantageous and further brings down the risk of long and transient entanglements.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3268

Company Profile

  • Boston Scientific Corporation
  • Medtronic plc.
  • Hollister Incorporate
  • B. Braun Melsungen AG
  • Coloplast A/S
  • Becton, Dickinson and Company
  • Teleflex Incorporation
  • Cook Medical

According to the report, increasing focus on advanced urinary catheters coated with hydrogel, teflon, silicon, elastomer, etc., is rising owing to increasing concern of regulatory bodies across all regions to reduce the infection during catheterization process.

Demand for Intermittent Urinary Catheters to Create Opportunities for Key Market Players

According to the PMR report, intermittent urinary catheters are likely to dominate the urinary catheters market during forecasted period, as these catheters are widely used for an effective bladder management strategy for patients with incomplete bladder emptying, due to idiopathic or neurogenic detrusor overactivity.

Urinary catheter sales are set to see an uptick, as they are relatively easy to use with just a simple procedure and can be used temporarily after certain types of surgery of prostate, genitals, or after an abdominal hysterectomy. Indwelling urinary catheters referred as “Foley” is a closed sterile system with catheters and balloon as external devices for collection of urine.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3268

The indwelling urinary catheters segment is expected to grow in the forecasted period at a CAGR ~3%, owing to its usage only for short duration, defined as less than 30 days (EAUN recommends no longer than 14 days).

Demand for urinary catheters increases with increase in application in various indications namely, urinary incontinence, urinary retention, prostate gland surgery, and spinal cord surgery.

Application for urinary catheters in prostate gland surgery will continue to account for greater sales, and it is estimated to shoot up by the end of 2029, due to increasing prevalence of benign prostatic hyperplasia (BPH) and prostate cancer. High application potential is also identified in urinary incontinence, due to its increasing prevalence among women population worldwide.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/3268

Investments in Asia Representing Scope for Future Market Growth

A large proportion of the geriatric population aged 65 or above across the globe suffer from urinary disorders, such as urinary retention and incontinence. The elderly population in developed regions such as North America, and Europe is increasingly using urinary catheters.

In contrast, urinary catheter usage penetration is relatively low in developing regions such as in Asia and Latin America, which represents scope of further penetration of urinary catheters in these regions.

Additionally, increasing healthcare spending and growing awareness among physicians and patients in developing Asian countries are expected to result in major opportunities for key players in the global market.

A research study by Persistence Market Research (PMR) analyzed that the Asian market for urinary catheters is expected to grow by CAGR ~ 4%. Accounting for ~ 23%  share, the Asian market opens new opportunities for key players to expand their footprint in the region, in the view of improved healthcare facilities and growing healthcare expenditure per capita.

]]>
The Pyrogen Testing Market To Take A Parabolic Turn With A CAGR Of 9% Fri, 15 Jan 2021 08:53:26 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683681.html persistencemarketresearch persistencemarketresearch The new market intelligence report by Persistence Market Research (PMR) reveals that the  global pyrogen testing market  will  reach US $ ~ 800 Mn  by the end of 2019, and further exhibit a  robust CAGR of 9%  through the next decade.

The increasing trend of outsourcing drug manufacturing to low-cost production regions by most pharmaceutical companies has been touted to remain a major influencer associated with the growth of pyrogen testing market landscape over the period of assessment, as it allows for low-cost skilled workforce and ease in tax relaxation.

Get Sample Copy of Report @  https://www.persistencemarketresearch.com/samples/4259

Company Profiles:

  • Thermo Fisher Scientific, Inc.
  • Merck & Co., Inc.
  • Associates of Cape Cod, Inc.
  • Charles River Laboratories, Inc.
  • GenScript
  • Lonza
  • Hyglos GmbH
  • Wako Chemicals USA, Inc.
  • Microcoat Biotechnologie GmbH

Growing Number of Pharmaceutical and Biotechnology Companies to Bring Traction to Pyrogen Testing

As medical devices cross the barriers within the body leading to contamination, pyrogen testing could be used by healthcare professionals to detect the harmful substances present in those devices. In addition, growing healthcare awareness also leads to upsurge in the medicine demand, which increases establishment of pharmaceuticals and biotechnology industries.

This in turn, propels the demand for pyrogen testing in these establishments worldwide. Moreover, increase in number of people diagnosed with various diseases results in the rising demand for various injectables, vaccines, tablets, and other medicines in turn, fueling the demand for safety measures such as pyrogen testing.

According to the PMR analysis, in end user, pharmaceutical companies will dominate the demand side in the pyrogen testing market by the end of 2019 and will also continue to exploit the highest share in the forecast period.

This is due to the growing number of pharmaceutical establishments in developed as well as developing countries, which increases the need for drug safety checks like pyrogen testing.

Demand for limulus amebocyte lysate (LAL) pyrogen testing is estimated to grow by the end of 2029, as end users demands for user-friendly pyrogen testing method that are cost-effective, and incur low equipment cost as well. Thus, the PMR study report estimates that LAL pyrogen testing method will harness around 60% of the global pyrogen testing market share during the forecast period.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/4259

Favorable Government Initiatives to Augur Well for Pyrogen Testing Market

Increasing spending by government bodies to develop effective drugs and medical devices is expected to drive the growth of the global pyrogen testing market in the forecast period. Pyrogen is a prominent cause that leads to shock or fatality among a large section of the patient population creating an economic burden on the country.

Thus, increasing healthcare spending is expected to result in growing demand for pyrogen testing by various pharmaceutical and medical device companies. Also, government in various countries are focused on of infectious diseases to reduce associated healthcare costs, which in turn prevention is expected to result in high demand for healthcare facilities.

In order to further complement this, government is focusing on pyrogen testing policies for contaminant-free medical devices and pharmaceuticals provided to the patient population, which will pave the way for the elevated requirement of pyrogen testing in the market.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/4259

Hence, companies operating in the pyrogen testing market are expected to largely benefit from such developments.

PMR's analysis also projects groundbreaking perspectives on the competitive business scenario of the pyrogen testing market along with highlights of participants' key business policies and approaches.

For instance, many drug manufacturing units are investing in foreign nations, especially in emerging economies of Asia Pacific and Latin America, which hold great future opportunities for the pyrogen testing market. Various pharmaceutical and medical device manufacturers are establishing their manufacturing base in India, China, and others in order to tap and cater to the unmet needs of the patient population in these regions, thus escalating the market for pyrogen testing.

]]>
The Ultrasonic Skin Care Devices Market To Grow Organically At A CAGR Of 5% Fri, 15 Jan 2021 08:53:04 +0100 http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html http://prwww.comunicati.net/comunicati/istituzioni/comuni/emilia_romagna/comune_di_ferrara/683680.html persistencemarketresearch persistencemarketresearch Persistence Market Research (PMR) published a report on the ultrasonic skin care devices market, which considers the global industry analysis 2014 - 2018 and opportunity assessment 2019 - 2029, and projects that  the ultrasonic skin care devices market  is expected to reach ~  US $ 440 Mn  by the end of 2019 in terms of value, and is forecasted to reach ~  US $ 720 Mn  by the end of 2029.

The presence of large number of companies is creating a healthy environment among the players. Companies with wide range of ultrasonic skin care devices are creating competitive environment for the other players in the market. The players are constantly working on developing better products to stay ahead of the pack.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/27490

Company Profiles:

  • Merz Pharma GmbH & Co. kGaA
  • Koninklijke Philips N.V
  • Iskra Medical d.o.o
  • Ibramed
  • Shenzhen Leaflife Technology Co., Ltd
  • Guangzhou Beautylife Electronic Technology Co., Ltd.
  • Ionto Health & Beauty Gmbh
  • Grand Aespio Inc.
  • Termosalud S.L
  • Adore cosmetics
  • Hironic Co. Ltd.
  • Bomtech Electronics co., Ltd
  • General Project Srl
  • Asterasys Co. Ltd.
  • Jellen Products Inc.

Companies such as Merz Pharma GmbH & Co. KGaA, Adore Cosmetics, Jellen Products, Inc. etc. are some of the prominent players in the market. Presence of local players including Shenzhen Bowei tech Co.ltd, Zerone Co., Ltd., and others are further likely to challenge the established companies.

Thus, these conditions are inciting manufacturers to come up with more advanced and improvised ultrasonic skin care devices.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/27490

Manufacturers to Tap Opportunities in Sales through E-commerce Sites

The online availability of the ultrasonic skin care devices has created a favorable condition for the market players. Most of the companies provide the international shipping services, and therefore the devices can be ordered from anywhere globally.

Many products are also available on online shopping sites such as amazon, flipkart, etc. and can be easily purchased by consumers, even in remote areas. These online websites also help in brand promotion and advertisement of ultrasonic skin care devices, thereby creating better opportunities for players.

Increasing Adoption of Home-based Skin Care Devices to Push the Market Growth

There is high demand for home care setting ultrasonic skin care devices which are user friendly and convenient to use. These ultrasonic skin care devices are cost effective and do not require any extra maintenance. Also, the procedure time for home care ultrasonic skin care devices are shorter as compared to table top devices and do not require professionals to operate.

Products such as palm sonic by Adore Cosmetics, Visa boost by Philips, PureCle Dr. by Bomtech Electronics co., Ltd. continue to account major share of the manufacturers' bottom lines. Home- based devices are easy to handle and do not require any professional assistance. These devices can be used for various applications such as skin tightening and skin rejuvenation, with better results.

Access Full Report @  https://www.persistencemarketresearch.com/checkout/27490

Table top devices are used in hospitals and clinics, and require professional experts to operate them. The ultrasonic skin care tabletop devices are widely used to overcome several skin related problems and to perform certain procedures like face lifting, skin tightening etc.

However, the cost of these ultrasonic skin care devices are high as compared to other handheld devices, thus representing a threat to the market growth. For instance, Ultherapy ultrasonic device manufactured by Merz Pharma GmbH & Co. KGaA are widely used in aesthetic clinics and has average price of  US $ 70000 . Such high cost of these devices are likely to act as a hindrance for the growth of the ultrasonic skin care devices market.

]]>